Related Experiment Video
Updated: May 21, 2026

10:49
Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus
Published on: January 28, 2019
New insights into rotavirus vaccines
Chiara Mameli1, Valentina Fabiano, Gian Vincenzo Zuccotti
1Department of Pediatrics, Luigi Sacco Hospital, University of Milan, Milan, Italy. mameli.chiara@hsacco.it
Human Vaccines & Immunotherapeutics
|June 16, 2012
Summary
Real-world data confirm rotavirus vaccines are effective and safe outside clinical trials. Post-licensure studies provide crucial insights into vaccine performance in routine immunization programs.
Area of Science:
- Vaccinology
- Public Health
- Infectious Diseases
Background:
- Rotavirus vaccines demonstrate high efficacy and tolerability in controlled clinical trials.
- Real-world immunization settings differ significantly from ideal clinical trial conditions.
- Evaluating vaccine performance in routine use is essential for public health.
Purpose of the Study:
- To review and synthesize published data on rotavirus vaccine impact in the post-licensure era.
- To assess the real-world effectiveness and safety of rotavirus vaccines.
- To provide an updated perspective on rotavirus vaccine performance under routine use.
Main Methods:
- Systematic review of published literature.
- Analysis of post-licensure observational studies.
- Evaluation of real-world data on vaccine effectiveness and safety.
Main Results:
- Post-licensure data confirm the effectiveness of rotavirus vaccines in preventing severe rotavirus gastroenteritis.
- Real-world safety profiles align with findings from clinical trials, indicating good tolerability.
- Routine use of rotavirus vaccines has led to significant reductions in disease burden.
Conclusions:
- Rotavirus vaccines are highly effective and safe when implemented in real-world public health programs.
- Post-licensure surveillance is critical for confirming vaccine benefits and monitoring safety.
- Continued use of rotavirus vaccines is strongly supported by real-world evidence.

